Exploring the pathogenesis linking primary aldosteronism and obstructive sleep apnea via bioinformatic analysis

Lanlan Zhao,Yuehua Dong,Ying Wei,Jie Li,Songyun Zhang
DOI: https://doi.org/10.1097/md.0000000000039468
IF: 1.6
2024-11-08
Medicine
Abstract:Primary aldosteronism (PA) is a common cause of secondary hypertension with a prevalence rate of approximately 5% to 10%. The characteristics of PA include excessive aldosterone secretion and inhibition of the renin-angiotensin system. Aldosterone-producing adenoma (APA) is a common subtype of PA, accounting for about 40% to 50% of PA cases. [ 1 ] Compared with essential hypertension, the incidence of stroke and myocardial infarction in PA patients is significantly higher, so early diagnosis and active treatment are crucial. [ 2 ] Obstructive sleep apnea (OSA) is a common sleep-related disorder. In recent years, with the rise in overweight and obese individuals, along with population aging, the occurrence of OSA has been escalating, becoming a pressing public health concern. [ 3 ] OSA poses a significant threat to life safety and may result in accidental deaths and sudden fatalities during sleep. [ 4 ] Furthermore, it exhibits a strong correlation with metabolic dysregulation, cardiovascular and nervous system impairments, as well as memory decline and cancer development. [ 5 ] Multiple studies reveal a close link between OSA and PA. A cross-center, multi-ethnic study found that 67.6% of PA patients had OSA, with a significant correlation between plasma aldosterone and OSA severity. [ 6 ] Nakamura et al discovered that 55% (39 of 71) of Japanese PA patients had OSA. [ 7 ] Therefore, conducting OSA examinations and implementing management strategies for PA patients is imperative. A meta-analysis revealed that OSA affects nearly 46% of 2335 PA patients (95% CI = 39–54%). Notably, hypertensive patients with PA have a significantly higher OSA prevalence compared to those without PA (OR = 2.01, 95% CI = 1.37–2.95, P < .001). In addition, the study demonstrated that approximately 27% of 3498 OSA patients also had PA (95% CI = 24–29%). Notably, the prevalence of PA was significantly higher in OSA patients compared to non-OSA patients (OR = 2.03, 95% CI = 1.30–3.16, P = .002). [ 8 ] Di Murro et al reported that approximately 34% of hypertensive patients with OSA also have PA. [ 9 ] Increasing research indicates that there is a complex interaction between OSA and PA, and they are likely to share some pathological mechanisms. [ 10 , 11 ] Despite numerous studies exploring the pathophysiological links between PA and OSA, the search for common genetic factors remains inadequate.
medicine, general & internal
What problem does this paper attempt to address?